BIOPHARMX

BPMX AMEX
0.4234
-0.0046
-1.07%
After Hours: 0.4170 -0.0064 -1.51% 17:41 07/19 EDT
Open
0.4300
Prev Close
0.4280
High
0.4500
Low
0.4088
Volume
241.33K
Avg Vol (3M)
1.06M
52 Week High
6.75
52 Week Low
0.4000
% Turnover
0.13%
Market Cap
80.45M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers BIOPHARMX BPMX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

BioPharmX Corporation is a specialty pharmaceutical company. The Company is focused on utilizing its drug delivery technologies to develop and commercialize prescription and over-the-counter (OTC) products that address markets in women's health and dermatology. Its portfolio of product candidates includes two clinical stage product candidates: BPX01, which is a topical antibiotic for the treatment of acne based on a formulation of minocycline, and BPX03, which is a molecular iodine (I2) tablet for the treatment of benign breast pain associated with fibrocystic breast condition (FBC) and cyclic mastalgia. Its VI2OLET is an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort and is clinically demonstrated to alleviate the symptoms associated with FBC, including tenderness, aches and swelling. It is developing BPX02, which is an injectable utilizing biologic materials for aesthetic dermatology applications.
MORE >

Recently

Name
Price
%Change